查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
放射性皮炎市场规模,份额和趋势分析报告：按产品（主题,皮质类固醇,亲水性乳膏,抗生素,敷料,水凝胶和水胶体）,分销渠道,地区,细分市场2023-2030
市场调查报告书
商品编码
1171046

放射性皮炎市场规模,份额和趋势分析报告：按产品（主题,皮质类固醇,亲水性乳膏,抗生素,敷料,水凝胶和水胶体）,分销渠道,地区,细分市场2023-2030

Radiodermatitis Market Size, Share & Trends Analysis Report By Product (Topical, Corticosteroids, Hydrophilic Creams, Antibiotics, Dressings, Hydrogel & Hydrocolloid), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

放射性皮炎市场的增长和趋势

根据 Grand View Research 的最新报告，到 2030 年，全球放射性皮炎市场预计将达到 5.571 亿美元。 从 2023 年到 2030 年，该市场预计将以 3.9% 的复合年增长率增长。 由于接受放射治疗的癌症患者数量不断增加，预计该市场将以前所未有的速度增长。 新兴国家和发达国家患者未满足的医疗需求也推动了对放射性皮炎治疗的需求。 此外，随着糖尿病和肥胖症的增加，患癌症的可能性也会增加。 这个因素可能会增加放射性皮炎的发生率和放射治疗的需要。 此外，饮酒和吸烟的增加是额外的癌症风险因素，这肯定会增加对放射性皮炎药物的需求。

COVID-19 大流行对放射性皮炎市场产生了重大影响。 在全球范围内，许多癌症中心报告说，在大流行期间诊断和治疗癌症的患者人数显着下降。 世界各地的医院在转向帮助应对 COVID-19 大流行病时减少了放射治疗。 然而，到了2020年第三季度，放鬆管制开始增加放疗，导致放射性皮炎市场增长。

亚太地区在预测期内的收入和增长方面主导着整个市场。 增加癌症研究活动、推进医疗保健基础设施以及支出的存在是获得该细分市场更大份额的一些因素。 此外，由于其未满足的需求，亚太地区可能在预测期内实现盈利增长。 北美排名第二。 辐射烧伤发病率的上升以及对皮肤移植物和替代品的高需求预计将进一步推动该市场的增长。

放射性皮炎市场报告要点

2022年产品品类中，外用剂品类获得最大份额。 这种压倒性的市场份额是由于其可用性、便利性和优于口服产品的优势。 此外，外用製剂预计将呈指数级增长，因为它们可以根据患者的需求提供各种製剂，例如乳膏、凝胶和软膏。

2022年，随着药店数量的增加，零售药店将在分销渠道中占据很大比重。 零售药店在医院处方中占比很大

由于癌症患者人数众多，亚太地区在该地区所占份额最高。

由于广泛的研发活动推动了潜在的增长机会，北美占第二大份额。 此外，北美高效产品的可用性是其高市场份额的主要原因之一。

竞争对手已实施产品发布、分销协议和战略联盟等战略，以显着增加其市场份额。

内容

第一章调查方法及范围

  • 按地区计算市场
    • 按地区划分的市场：基本估计
    • 全球市场：CAGR 计算
  • 按地区计算细分市场份额
  • 二级信息列表

第 2 章执行摘要

第 3 章放射性皮炎市场变量、趋势和范围

  • 市场细分和范围
  • 市场驱动因素分析
  • 市场製约因素分析
  • 描绘渗透率和增长前景
  • 辐射性皮炎市场 SWOT 分析，按因素（政治与法律、经济与技术）
  • 行业分析 - 搬运工
  • COVID-19 影响分析

第 4 章放射性皮炎市场：产品估计和趋势分析

  • 放射性皮炎市场：产品差异分析
  • 本地
    • 皮质类固醇
    • 亲水霜
    • 抗生素
    • 其他
  • 口语
  • 覆盖材料
    • 水凝胶和水胶体敷料
    • 无刺阻隔膜
    • 蜂蜜浸渍纱布
    • 硅涂层敷料
    • 其他

第 5 章放射性皮炎市场：分销渠道估计和趋势分析

  • 放射性皮炎市场：分销渠道的变化分析
  • 医院药房
  • 零售药房
  • 在线药店

第 6 章放射性皮炎市场：按产品和分销渠道划分的区域估计和趋势分析

  • 2022 年和 2030 年按地区划分的放射性皮炎市场份额
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第七章竞争格局

  • 战略框架
  • 市场参与分类
  • 公司简介
    • Stratpharma AG
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Smith &Nephew
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Molnlycke Health Care AB
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Derma Sciences Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • ConvaTec Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • BMG Pharma SRL
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Acelity
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 3M
      • 公司简介
      • 财务业绩
      • 产品基准
    • Alliqua BioMedical
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-1-68038-857-2

Radiodermatitis Market Growth & Trends:

The global radiodermatitis market size is expected to reach USD 557.1 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.9% from 2023 to 2030. The market is expected to grow at an unprecedented rate owing to the growing prevalence of cancer patients undergoing radiation therapy. The unmet medical needs of patients in both emerging and developed nations are another factor that increases the demand for radiodermatitis treatment. As the prevalence of diabetes and obesity increases, these individuals are more likely to suffer from cancer. This factor is probably going to increase the cases of radiodermatitis and increase the need for radiation therapy. Furthermore, higher consumption of alcohol and smoking are additional cancer risk factors, which will certainly increase demand for radiodermatitis medications.

The COVID-19 pandemic has a significant impact on the radiodermatitis market. Various regions imposed restrictions or lockdowns of varying severity implemented to curb the pandemic, with different outcomes.Globally, many cancer centers have reported substantial decreases in the number of patients diagnosed with and treated for cancer during the pandemic. Hospitals across the globe have decreased radiotherapy treatment as there was a shift to support the COVID-19 pandemic. However, with the ease of the restrictions by the 3rd quarter of 2020, radiotherapy treatment started to increase which resulted in the growth of the radiodermatitis market.

Asia Pacific dominated the overall market in terms of revenue and growth rate during the forecast period. The presence of increasing cancer research activities, advancing healthcare infrastructure, and expenditure are some of the factors responsible for garnering a greater share of the segment. As a result of unmet patient needs, Asia Pacific is also likely to have profitable expansion over the course of the projection period. The market's second-largest share was accounted for by North America. The increasing incidence of radiation burns along with the high demand for skin grafts and substitutes is expected to further drive the growth of this market.

Radiodermatitis Market Report Highlights:

  • The topical products segment captured the largest share in the product segment in 2022. The dominant share is attributable to ease in availability, greater convenience, and superiority over oral products. Topical products are also anticipated to grow at an exponential rate owing to their availability in various formulations such as creams, gels, and ointments according to the requirement of the patient
  • In 2022, the retail pharmacies segment accounted for a substantial share of the distribution channel segment owing to the rising number of pharmacies. The retail pharmacies may capture large percent of prescriptions written in the hospital
  • Due to the high number of cancer patients in this area, Asia Pacific held the highest share of the market
  • North America held the second largest share owing to extensive R&D activities that have fueled high-potential growth opportunities. In addition, the availability of therapeutically advanced products across North America is one of the major factors contributing toward its high share
  • The competition is marked by major players undertaking strategies such as product launches, distribution agreements, and strategic collaborations that have led to significant growth in their respective market share

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Region Wise Market Calculation
    • 1.1.1 Region-wise market: Base estimates
    • 1.1.2 Global market: CAGR calculation
  • 1.2 Region-Based Segment Share Calculation
  • 1.3 List of Secondary Sources

Chapter 2 Executive Summary

Chapter 3 Radiodermatitis Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
  • 3.3 Market Restraint Analysis
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 Radiodermatitis Market - SWOT Analysis, By Factor (Political & legal, economic and technological)
  • 3.6 Industry Analysis - Porter's
  • 3.7 COVID-19 Impact Analysis

Chapter 4 Radiodermatitis Market: Product Estimates & Trend Analysis

  • 4.1 Radiodermatitis Market: Product Movement Analysis
  • 4.2 Topical
    • 4.2.1 Topical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2 Corticosteroids
      • 4.2.2.1 Corticosteroids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3 Hydrophilic Creams
      • 4.2.3.1 Hydrophilic Creams Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4 Antibiotics
      • 4.2.4.1 Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.5 Others
      • 4.2.5.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.3 Oral
    • 4.3.1 Oral Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4 Dressings
    • 4.4.1 Dressings Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2 Hydrogel & Hydrocolloid Dressing
      • 4.4.2.1 Hydrogel & Hydrocolloid Dressing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3 No Sting Barrier Film
      • 4.4.3.1 No Sting Barrier Film Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4 Honey Impregnated Gauze
      • 4.4.4.1 Honey Impregnated Gauze Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5 Silicone Coated Dressings
      • 4.4.5.1 Silicone Coated Dressings Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6 Others
      • 4.4.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Radiodermatitis Market: Distribution Channel Estimates & Trend Analysis

  • 5.1 Radiodermatitis Market: Distribution Channel Movement Analysis
  • 5.2 Hospital Pharmacies
    • 5.2.1 Hospital Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3 Retail Pharmacies
    • 5.3.1 Retail Pharmacies Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4 Online Pharmacies
    • 5.4.1 Online Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Radiodermatitis Market: Regional Estimates & Trend Analysis, by Product & Distribution Channel

  • 6.1 Radiodermatitis Market Shares By Region, 2022 & 2030
  • 6.2 North America
    • 6.2.1 North America Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
    • 6.2.2 North America Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.2.3 U.S.
      • 6.2.3.1 U.S. Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.2.3.2 U.S. Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.2.4 Canada
      • 6.2.4.1 Canada Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.2.4.2 Canada Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
    • 6.3.2 Europe Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.3.3 U.K.
      • 6.3.3.1 U.K. radiodermatitis Market Estimates And Forecasts, 2018 - 2030(USD Million)
      • 6.3.3.2 U.K. Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.3.3.3 U.K. Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.3.4 Germany
      • 6.3.4.1 Germany Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.3.4.2 Germany Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.3.5 France
      • 6.3.5.1 France Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.3.5.2 France Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.3.6 Italy
      • 6.3.6.1 Italy Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.3.6.2 Italy Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.3.7 Spain
      • 6.3.7.1 Spain Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.3.7.2 Spain Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.3.8 Denmark
      • 6.3.8.1 Denmark Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.3.8.2 Denmark Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.3.9 Sweden
      • 6.3.9.1 Sweden Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.3.9.2 Sweden Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.3.10 Norway
      • 6.3.10.1 Norway Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.3.10.2 Norway Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
    • 6.4.2 Asia Pacific Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.4.3 Japan
      • 6.4.3.1 Japan Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.4.3.2 Japan Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.4.4 China
      • 6.4.4.1 China Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.4.4.2 China Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.4.5 India
      • 6.4.5.1 India Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.4.5.2 India Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.4.6 Australia
      • 6.4.6.1 Australia Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.4.6.2 Australia Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.4.7 South Korea
      • 6.4.7.1 South Korea Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.4.7.2 South Korea Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.4.8 Thailand
      • 6.4.8.1 Thailand Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.4.8.2 Thailand Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
    • 6.5.2 Latin America Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.5.3 Brazil
      • 6.5.3.1 Brazil Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.5.3.2 Brazil Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.5.4 Mexico
      • 6.5.4.1 Mexico Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.5.4.2 Mexico Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.5.5 Argentina
      • 6.5.5.1 Argentina Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.5.5.2 Argentina Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
    • 6.6.2 MEA Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.6.3 South Africa
      • 6.6.3.1 South Africa Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.6.3.2 South Africa Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.6.4 Saudi Arabia
      • 6.6.4.1 Saudi Arabia Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.6.4.2 Saudi Arabia Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.6.5 UAE
      • 6.6.5.1 UAE Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.6.5.2 UAE Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
    • 6.6.6 Kuwait
      • 6.6.6.1 Kuwait Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
      • 6.6.6.2 Kuwait Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Strategy Framework
  • 7.2 Market Participation Categorization
  • 7.3 Company Profiles
    • 7.3.1 Stratpharma AG
      • 7.3.1.1 Company Overview
      • 7.3.1.2 Financial performance
      • 7.3.1.3 Product benchmarking
      • 7.3.1.4 Strategic initiatives
    • 7.3.2 Smith & Nephew
      • 7.3.2.1 Company Overview
      • 7.3.2.2 Financial Performance
      • 7.3.2.3 Product Benchmarking
      • 7.3.2.4 Strategic initiatives
    • 7.3.3 Molnlycke Health Care AB
      • 7.3.3.1 Company Overview
      • 7.3.3.2 Financial Performance
      • 7.3.3.3 Product Benchmarking
      • 7.3.3.4 Strategic initiatives
    • 7.3.4 Derma Sciences Inc.
      • 7.3.4.1 Company Overview
      • 7.3.4.2 Financial Performance
      • 7.3.4.3 Product Benchmarking
      • 7.3.4.4 Strategic initiatives
    • 7.3.5 ConvaTec Inc.
      • 7.3.5.1 Company Overview
      • 7.3.5.2 Financial performance
      • 7.3.5.3 Product benchmarking
      • 7.3.4.4 Strategic initiatives
    • 7.3.6 BMG Pharma S.R.L.
      • 7.3.6.1 Company Overview
      • 7.3.6.2 Financial performance
      • 7.3.6.3 Product benchmarking
      • 7.3.6.4 Strategic initiatives
    • 7.3.7 Acelity
      • 7.3.7.1 Company Overview
      • 7.3.7.2 Financial performance
      • 7.3.7.3 Product benchmarking
      • 7.3.7.4 Strategic initiatives
    • 7.3.8 3M
      • 7.3.8.1 Company Overview
      • 7.3.8.2 Financial Performance
      • 7.3.8.3 Product Benchmarking
    • 7.3.9 Alliqua BioMedical
      • 7.3.9.1 Company Overview
      • 7.3.9.2 Financial performance
      • 7.3.9.3 Product benchmarking
      • 7.3.4.4 Strategic initiatives

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of Abbreviations

List of Figures

  • FIG. 1 Market outlook
  • FIG. 2 Market segmentation & scope
  • FIG. 3 Market driver relevance analysis (Current & future impact)
  • FIG. 4 Market restraint relevance analysis (Current & future impact)
  • FIG. 5 Penetration & growth prospect mapping
  • FIG. 6 SWOT Analysis, By Factor (Political & legal, economic and technological)
  • FIG. 7 Porter's Five Forces Analysis
  • FIG. 8 Radiodermatitis market, product outlook: Key takeaways
  • FIG. 9 Radiodermatitis market: Product movement analysis
  • FIG. 10 Global topical market, 2018 - 2030 (USD Million)
  • FIG. 11 Global corticosteroid market, 2018 - 2030 (USD Million)
  • FIG. 12 Global hydrophilic creams market, 2018 - 2030 (USD Million)
  • FIG. 13 Global antibiotics market, 2018 - 2030 (USD Million)
  • FIG. 14 Global others market, 2018 - 2030 (USD Million)
  • FIG. 15 Global oral market, 2018 - 2030 (USD Million)
  • FIG. 16 Global dressings market, 2018 - 2030 (USD Million)
  • FIG. 17 Global hydrogel & hydrocolloid dressing market, 2018 - 2030 (USD Million)
  • FIG. 18 Global no sting barrier film market, 2018 - 2030 (USD Million)
  • FIG. 19 Global honey impregnated gauze market, 2018 - 2030 (USD Million)
  • FIG. 20 Global silicone coated dressings market, 2018 - 2030 (USD Million)
  • FIG. 21 Global others market, 2018 - 2030 (USD Million)
  • FIG. 22 Radiodermatitis market, distribution channel outlook: Key takeaways
  • FIG. 23 Radiodermatitis market: Distribution channel movement analysis
  • FIG. 24 Global hospital pharmacies market, 2018 - 2030 (USD Million)
  • FIG. 25 Global retail pharmacies market, 2018 - 2030 (USD Million)
  • FIG. 26 Global online pharmacies market, 2018 - 2030 (USD Million)
  • FIG. 27 Regional market place: Key takeaways
  • FIG. 28 Regional outlook, 2022 & 2030
  • FIG. 29 U.S. Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 30 Canada radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 31 Germany Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 32 U.K. radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 33 Germany Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 34 France radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 35 Italy Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 36 Spain radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 37 Denmark Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 38 Sweden radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 39 Norway Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 40 China radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 41 Japan Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 42 India radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 43 Australia Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 44 South Korea radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 45 Thailand Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 46 Brazil radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 47 Mexico Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 48 Argentina radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 49 South Africa Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 50 Saudi Arabia radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 51 UAE Radiodermatitis market, 2018 - 2030 (USD Million)
  • FIG. 52 Kuwait radiodermatitis market, 2018 - 2030 (USD Million)